Log in
0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Industries
Headquarters
Stage
Employees
Links
Ben Bergo
9 members
4 members
BioMarin Pharmaceutical
22 followers
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Verve Therapeutics
53 followers
Discover companies